NeuroSense Therapeutics Cash Flow Statement 2019-2024 | NRSN

Fifteen years of historical annual cash flow statements for NeuroSense Therapeutics (NRSN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-11.28$-12.34$-4.04$-2.83$-1.22
$0.10$0.09$0.00$0.00$0
$0.82$3.92$2.23$2.06$0.61
$0.92$4.00$2.23$2.06$0.61
$0.02$0.06$-0.20$-0.01$0.00
$0$0$0$0$0
$1.89$0.70$0.48$0.08$0.03
$0$0$0$0$0
$1.91$0.75$0.27$0.07$0.03
$-8.45$-7.59$-1.54$-0.70$-0.58
$-0.03$-0.07$-0.02$-0.01$-0.01
$0$0$0$0$0
$0$0$0$0$0
$3.50$-3.50$0$0$0
$0.00$-0.02$0$0$-0.02
$3.50$-3.52$0$0$-0.02
$0.18$0.05$0$0$0
$3.65$-3.54$-0.02$-0.01$-0.03
$0$0$0$0$0
$-0.08$-0.08$0$0$0.00
$-0.08$-0.08$0$0$0.00
$3.98$3.87$11.90$0.51$1.42
$3.98$3.87$11.90$0.51$1.42
$0$0$0$0$0
$0$-0.10$0$0$0
$3.90$3.70$11.90$0.51$1.42
$-0.90$-7.52$10.36$-0.20$0.81
$2.80$5.11$4.16$2.06$0.61
$0$0$0$0$0